A Study of NX-1607 in Adults With Advanced Malignancies
for Ovarian Cancer, Epithelial
Sites in Oklahoma City +8 more locations
Sponsor: Nurix Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05107674·Phase 1·Recruiting·Listed Nov 2021
Oncology Clinical Trials in Oklahoma City, OK
As of September 2026, 142 paid clinical trials are recruiting for Oncology in Oklahoma City, Oklahoma. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
144 clinical trials for Oncology
·Clear filters· Email me when a new oncology trial opens in Oklahoma City, OK.
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
for Cancer
Sites in Oklahoma City +7 more locations
Sponsor: Elephas
Sex: All·Age: 18+
Code: NCT07327489·Recruiting·Listed Jan 2026
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
for Ovarian Cancer
Sites in Oklahoma City +7 more locations
Sponsor: Tubulis GmbH
Sex: All·Age: 18+
Code: NCT06303505·Phase 1, Phase 2·Recruiting·Listed Mar 2024
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in Oklahoma City +14 more locations
Sponsor: Vividion Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023
A Study of DM002 in Patients With Advanced Solid Tumors
for Ovarian Neoplasms
Sites in Oklahoma City +3 more locations
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Sex: All·Age: 18+
Code: NCT06751329·Phase 1, Phase 2·Recruiting·Listed Dec 2024
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for Ovarian Cancer
Drug: IMNN-001
Sites in Oklahoma City +1 more location
Sponsor: Imunon
Sex: Female·Age: 18+
Code: NCT05739981·Phase 1, Phase 2·Recruiting·Listed Feb 2023
Clinical Pre-screening Protocol for Ovarian Cancer
for Ovarian Cancer
Sites in Oklahoma City +6 more locations
Sponsor: Allarity Therapeutics
Sex: Female·Age: 18+
Code: NCT03877796·Recruiting·Listed Mar 2019
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
for Gynecologic Cancers
Sites in Oklahoma City +7 more locations
Sponsor: AbbVie
Sex: Female·Age: 18+
Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for Non Small Cell Lung Cancer
Sites in Oklahoma City +4 more locations
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05431270·Phase 1, Phase 2·Recruiting·Listed Jun 2022
Combination of TATE and PD-1 Inhibitor in Liver Cancer
for Hepatocellular Carcinoma
Sites in Oklahoma City +2 more locations
Sponsor: Teclison Ltd.
Sex: All·Age: 18 - 80
Code: NCT03259867·Phase 2·Recruiting·Listed Aug 2017
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
for Endometrial Cancer
Sites in Oklahoma City +8 more locations
Sponsor: Aadi Bioscience, Inc.
Sex: All·Age: 18+
Code: NCT05997017·Phase 2·Recruiting·Listed Aug 2023
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
for Lung Non-Small Cell Carcinoma
Drug: Atezolizumab
Sites in Oklahoma City +58 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT07388524·Phase 3·Recruiting·Listed Feb 2026
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
Sites in Oklahoma City +180 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 65+
Code: NCT07321652·Phase 3·Recruiting·Listed Jan 2026
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
for Lung Non-Small Cell Carcinoma
Sites in Oklahoma City, Lawton +621 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
for Breast Cancer
Sites in Oklahoma City, Lawton +1098 more locations
Sponsor: NRG Oncology
Sex: Female·Age: 18 - 60
Code: NCT05879926·Phase 3·Recruiting·Listed May 2023
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
for Head and Neck Squamous Cell Carcinoma
Sites in Oklahoma City +462 more locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All·Age: 18+
Code: NCT02734537·Phase 2·Recruiting·Listed Apr 2016
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
for Acute Lymphoblastic Leukemia
Sites in Oklahoma City +617 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 40 - 75·Accepts healthy volunteers
Code: NCT05334069·Recruiting·Listed Apr 2022
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for Chronic Lymphocytic Leukemia
Sites in Oklahoma City +296 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04269902·Phase 3·Recruiting·Listed Feb 2020
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for Fallopian Tube Endometrioid Adenocarcinoma
Drug: Bevacizumab
Sites in Oklahoma City +654 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06580314·Phase 3·Recruiting·Listed Aug 2024
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
for Malignant Solid Neoplasm
Sites in Oklahoma City +354 more locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All·Age: All ages·Accepts healthy volunteers
Code: NCT06295367·Recruiting·Listed Mar 2024
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for Biochemically Recurrent Prostate Carcinoma
Drug: Apalutamide
Sites in Oklahoma City +277 more locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male·Age: 18+
Code: NCT04423211·Phase 3·Recruiting·Listed Jun 2020
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for Ovarian Carcinoma
Sites in Oklahoma City +480 more locations
Sponsor: NRG Oncology
Sex: Female·Age: 35 - 50
Code: NCT04251052·Recruiting·Listed Jan 2020
E-Mindfulness Approaches for Living After Breast Cancer
for Breast Cancer
Sites in Oklahoma City +373 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18 - 50
Code: NCT06748222·Phase 3·Recruiting·Listed Dec 2024
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for Acute Myeloid Leukemia
Sites in Oklahoma City +329 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05564390·Phase 2·Recruiting·Listed Oct 2022
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for Metastatic Renal Cell Carcinoma
Sites in Oklahoma City, Tulsa +278 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05327686·Phase 2·Recruiting·Listed Apr 2022
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for Advanced Malignant Solid Neoplasm
Sites in Oklahoma City +430 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: All ages
Code: NCT05564377·Phase 2·Recruiting·Listed Oct 2022
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for Clinical Stage III Cutaneous Melanoma AJCC v8
Drug: Cabozantinib
Sites in Oklahoma City +208 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05136196·Phase 2·Recruiting·Listed Nov 2021
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for Mantle Cell Lymphoma
Sites in Oklahoma City, Lawton +228 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 60+
Code: NCT05976763·Phase 3·Recruiting·Listed Aug 2023
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for Lung Non-Small Cell Carcinoma
Sites in Oklahoma City +265 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06498635·Phase 3·Recruiting·Listed Jul 2024
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Sites in Oklahoma City +205 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18 - 59
Code: NCT05554406·Phase 2·Recruiting·Listed Sep 2022
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Drug: Venetoclax
Sites in Oklahoma City +215 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06317649·Phase 2·Recruiting·Listed Mar 2024
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for Myelodysplastic Syndrome
Sites in Oklahoma City +137 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06577441·Phase 2·Recruiting·Listed Aug 2024
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Sites in Oklahoma City +145 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06532279·Phase 2·Recruiting·Listed Aug 2024
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for Hematopoietic and Lymphatic System Neoplasm
Sites in Oklahoma City +190 more locations
Sponsor: Children's Oncology Group
Sex: Female·Age: Up to 39
Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Drug: Venetoclax
Sites in Oklahoma City +171 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18 - 59
Code: NCT05554393·Phase 2·Recruiting·Listed Sep 2022
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for Cervical Cancer
Sites in Oklahoma City +116 more locations
Sponsor: GOG Foundation
Sex: Female·Age: 18+
Code: NCT04831580·Recruiting·Listed Apr 2021
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Sites in Oklahoma City +128 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06672146·Phase 2·Recruiting·Listed Nov 2024
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
for Anatomic Stage IV Breast Cancer AJCC v8
Sites in Oklahoma City +256 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06500455·Phase 3·Recruiting·Listed Jul 2024
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
for Hodgkin Lymphoma
Sites in Oklahoma City +404 more locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All·Age: 18+
Code: NCT06002828·Recruiting·Listed Aug 2023
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for Malignant Female Reproductive System Neoplasm
Sites in Oklahoma City +177 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06126276·Phase 2·Recruiting·Listed Nov 2023
Conditions in Oncology (Oklahoma City, OK)
Solid tumor· 30Non-small cell lung cancer (NSCLC)· 23Ovarian cancer· 17Endometrial cancer· 17Acute myeloid leukemia (AML)· 13Breast cancer· 12Cancer (any)· 11Colorectal cancer· 10Pancreatic cancer· 10Prostate cancer· 10Head and neck cancer· 10Hematologic malignancy· 9Fallopian tube cancer· 8Gastric cancer· 5Liver cancer· 5Bladder cancer· 5Cervical cancer· 5Melanoma· 5Triple-negative breast cancer· 4Kidney cancer· 4Non-Hodgkin lymphoma· 4Diffuse large B-cell lymphoma (DLBCL)· 4Lung cancer· 3Esophageal cancer· 3Gastroesophageal junction cancer· 3Chronic lymphocytic leukemia (CLL)· 3Leukemia (other)· 3Myelodysplastic syndromes (MDS)· 3Metastatic breast cancer· 2HER2-positive breast cancer· 2HER2-negative breast cancer· 2Uterine cancer· 2Multiple myeloma· 2Acute lymphoblastic leukemia· 2Hodgkin lymphoma· 2Skin cancer· 2Osteosarcoma· 2Neuroblastoma· 2Small cell lung cancer· 1Metastatic colorectal cancer· 1Colon cancer· 1Gastrointestinal cancer· 1Metastatic prostate cancer· 1Myeloproliferative neoplasm· 1Mantle cell lymphoma· 1Small lymphocytic lymphoma· 1Burkitt lymphoma· 1Sarcoma· 1Mesothelioma· 1